ngt-pharma-masthead

Customized Solutions for Complex Challenges

MEET OUR TEAM

NGT BioPharma Consultants: Innovative Minds for Transformative Results

Mike K. O'Brien NGT BioPharma Consultants

Michael K. O’Brien, PhD

President & CEO

Ed Herpel NGT BioPharma Consultants

Ed Herpel, MA

VP Organizational Effectiveness & Development

Rachel Franckowiak, Senior Administrative Assistant

Rachel Franckowiak, BA

Senior Executive Coordinator

Mark Zettler PhD NGT BioPharma Consultants

Mark Zettler, PhD

API and Formulation R&D

Alton Johnson, PhD

Manufacturing Operations,
Drug Development

Malcolm Berry, PhD - Multi-Stage Continuous Processing for APIs

Malcolm Berry, PhD

Multi-Stage Continuous Processing for APIs

Ronay LeBlanc, MA

Quality & Compliance

 Nancy C. Motola, PhD, RAC

Regulatory, Compliance, Quality Assurance

 

Steve Hammond

Process Analytics and
PAT Innovator

Michael Placke, NGT Biopharma Consultants

Michael Placke, PhD, DABT

Nonclinical Development
and Drug Safety

 

David Lowenschuss, NGT BioPharma Consultants Partner

David Lowenschuss, JD

Biotech and Life Sciences
Legal Counsel

Frank Orlowski Portrait, NGT Pharma Consultants Principal

Frank P. Orlowski, MBA

Biotech and Life Sciences
Global Finance

Robert Dennehy, PhD

API Crystallization and Solid State

Leo J. Adalbert

Principal Consultant –
Strategic Commercialization

Philip Chu, PhD

Associate Consultant

NGT BioPharma Consultants, John Dillon

John L. Dillon, PhD

API Process R&D, Synthetic Organic Chemistry